Mesenchymal Stromal Cell-Based Therapy

Dina Mönch; Marlies E J Reinders; Martin J Hoogduijn; Marc-Hendrik Dahlke

doi:10.3390/cells12040559

Mesenchymal Stromal Cell-Based Therapy

Cells. 2023 Feb 9;12(4):559. doi: 10.3390/cells12040559.

Authors

Dina Mönch^{1

2}, Marlies E J Reinders³, Martin J Hoogduijn³, Marc-Hendrik Dahlke⁴

Affiliations

¹ Dr. Margarete Fischer-Bosch Institute of Clinical Pharmacology, 70376 Stuttgart, Germany.
² University of Tübingen, 72074 Tübingen, Germany.
³ Erasmus MC Transplant Institute, Department of Internal Medicine, Erasmus University Medical Center, 3015 GD Rotterdam, The Netherlands.
⁴ Department of Surgery, Robert-Bosch-Hospital, 70376 Stuttgart, Germany.

Abstract

The use of mesenchymal stromal cells (MSCs) for clinical application is intensively investigated for a variety of areas, such as bone repair, haematological and autoimmune diseases, and solid organ transplantation [...].

Publication types

Editorial
Research Support, Non-U.S. Gov't

MeSH terms

Autoimmune Diseases*
Humans
Mesenchymal Stem Cell Transplantation*
Mesenchymal Stem Cells*
Organ Transplantation*

Grants and funding

M.H.D. and D.M. are supported by the Robert Bosch Stiftung, Stuttgart.